Biocon Limited has informed the Exchange regarding a press release dated October 03, 2024, titled "Biocon Biologics Refinances USD 1.1 Billion (INR 93,468 million) Long Term Debt through USD Bonds and New Syndicated Facility".
Press Release Oct 03 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Biocon
- Biocon Limited partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
- Press Release Sep 26 2024
- Press Release Sep 25 2024
- Press Release Aug 29 2024
- Press Release Aug 08 2024
Later from Biocon
- Press Release Oct 08 2024
- Biocon Biologics Announces Results of Aflibercept Switching Study at American Academy of Ophthalmology Annual Meeting
- Press Release Oct 25 2024
- Press Release Oct 28 2024
- Press Release Oct 30 2024
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon